Raymond J. Kelleher Receives Stock Award at BridgeBio Oncology Therapeutics Inc (BBOT) — SEC Form 4, Jun 18, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Raymond J. Kelleher CIK 0002058193 |
Director
|
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.73 | 2026-06-16 | A - Award/Grant | 31,675 A | $0.00 | 2036-06-15 | 31,675 Common Stock | Direct |
Footnotes (1)
- F1
- The shares underlying the stock option vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting of Stockholders of the Issuer following the date of grant, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Show more
Related filings at BridgeBio Oncology Therapeutics Inc
5%+ Holders · 13D/G
7 filers
-
Chen Bihua 22.3%
-
Deerfield Mgmt, L.P. 6.2%
-
BridgeBio Pharma LLC 17.5%
-
Helix Holdings II LLC 22.6%
Other insiders at BridgeBio Oncology Therapeutics Inc
GET /v1/forms/4/0001193125-26-276043
API docs
View Original SEC Filing